Treatment patterns and outcomes in advanced clear cell sarcoma and gastrointestinal neuroectodermal tumors.
BACKGROUND: Clear cell sarcoma (CCS) and gastrointestinal neuroectodermal tumor (GNET) are ultra-rare soft tissue sarcomas with no established standard of care for advanced disease. Outcomes remain poor, highlighting the need for novel therapies and collaborative studies.
BACKGROUND: Clear cell sarcoma (CCS) and gastrointestinal neuroectodermal tumor (GNET) are ultra-rare soft tissue sarcomas with no established standard of care for advanced disease. Outcomes remain poor, highlighting the need for novel therapies and collaborative studies.
What the study was
- Study design
- Observational/Descriptive Study
- Category
- Drug Development
- Maturity
- Exploratory
- Journal
- JNCI cancer spectrum
Why it surfaced
Score 8/10: Observational/Descriptive Study matching topic 'Rare diseases with high unmet need'; flagged NEAR_TERM_IMPLEMENTABLE
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.